Basiliximab是严重肝脏慢性GVHD的潜在解决方案:一项前瞻性试点研究

Dao-Xing Deng, Mengzhu Shen, Xiaohui Zhang, Lanping Xu, Yu Wang, Chen‐hua Yan, Yuhong Chen, Huan Chen, W. Han, Feng‐rong Wang, Jing‐zhi Wang, Xiaojun Huang, X. Mo
{"title":"Basiliximab是严重肝脏慢性GVHD的潜在解决方案:一项前瞻性试点研究","authors":"Dao-Xing Deng, Mengzhu Shen, Xiaohui Zhang, Lanping Xu, Yu Wang, Chen‐hua Yan, Yuhong Chen, Huan Chen, W. Han, Feng‐rong Wang, Jing‐zhi Wang, Xiaojun Huang, X. Mo","doi":"10.59717/j.xinn-med.2023.100009","DOIUrl":null,"url":null,"abstract":"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a crucial curative method to treat hematologic malignancies and non-malignant hematologic disorder. 1,","PeriodicalId":423184,"journal":{"name":"The Innovation Medicine","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study\",\"authors\":\"Dao-Xing Deng, Mengzhu Shen, Xiaohui Zhang, Lanping Xu, Yu Wang, Chen‐hua Yan, Yuhong Chen, Huan Chen, W. Han, Feng‐rong Wang, Jing‐zhi Wang, Xiaojun Huang, X. Mo\",\"doi\":\"10.59717/j.xinn-med.2023.100009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a crucial curative method to treat hematologic malignancies and non-malignant hematologic disorder. 1,\",\"PeriodicalId\":423184,\"journal\":{\"name\":\"The Innovation Medicine\",\"volume\":\"60 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Innovation Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59717/j.xinn-med.2023.100009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Innovation Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59717/j.xinn-med.2023.100009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

同种异体造血干细胞移植是治疗恶性血液病和非恶性血液病的重要方法。1,
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a crucial curative method to treat hematologic malignancies and non-malignant hematologic disorder. 1,
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信